Joe Bolen

Joe Bolen

President chez
Orna Therapeutics, Inc.
72 ans
Health Technology
Consumer Services
Finance

Profil

Dr. Joseph B. Bolen is an Independent Director at Aelin Therapeutics NV and a President & Director at Orna Therapeutics, Inc. He is on the Board of Directors at Aelin Therapeutics NV and Orna Therapeutics, Inc. Dr. Bolen was previously employed as a Partner by MPM BioImpact LLC, a Chief Scientific Officer by PureTech Health Plc, a President & Chief Scientific Officer by ModernaTX, Inc., a Chief Scientific Officer & Head-Oncology Research by Millennium Pharmaceuticals, Inc., an Executive Director-Oncology Drug Discovery by Bristol-Myers Squibb Pharma Research Labs LLC, a Founding Director by DNAX Research, Inc., a Vice President & Head-Oncologic Diseases by Hoechst Marion Roussel, Inc., a President & Chief Scientific Officer by Moderna, Inc., a Scientist by National Institutes of Health, a Professor by Princeton University, an Advisor by Robert Wood Johnson Medical School, and a Member-Scientific Advisory Board by Rutgers State University of New Jersey.
He received his undergraduate degree from the University of Nebraska and a doctorate degree from Kansas State University.

Postes actifs de Joe Bolen

SociétésPosteDébut
Directeur/Membre du Conseil -
President -

Anciens postes connus de Joe Bolen

SociétésPosteFin
Private Equity Investor 01/06/2026
PURETECH HEALTH PLC Directeur Technique/Scientifique/R&D 01/02/2023
MODERNA, INC. President -
Directeur Technique/Scientifique/R&D -
DNAX Research, Inc.
Corporate Officer/Principal -
Voir l'expérience en détail de Joe Bolen

Formation de Joe Bolen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

41

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Health Technology

Consumer Services

Finance

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Government

Consumer Services

Health Technology

DNAX Research, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology